Nisa Investment Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $79.2K | Buy |
1,254
+14
| +1% | +$885 | ﹤0.01% | 1468 |
|
2025
Q1 | $65.7K | Sell |
1,240
-45
| -4% | -$2.38K | ﹤0.01% | 1509 |
|
2024
Q4 | $71.9K | Sell |
1,285
-64,955
| -98% | -$3.64M | ﹤0.01% | 1569 |
|
2024
Q3 | $3.47M | Sell |
66,240
-308,107
| -82% | -$16.1M | 0.02% | 515 |
|
2024
Q2 | $15.4M | Buy |
374,347
+229,056
| +158% | +$9.41M | 0.1% | 205 |
|
2024
Q1 | $6.3M | Buy |
145,291
+144,035
| +11,468% | +$6.24M | 0.04% | 379 |
|
2023
Q4 | $57.7K | Buy |
1,256
+600
| +91% | +$27.6K | ﹤0.01% | 1607 |
|
2023
Q3 | $15K | Buy |
656
+620
| +1,722% | +$14.2K | ﹤0.01% | 2089 |
|
2023
Q2 | $594 | Buy |
+36
| New | +$594 | ﹤0.01% | 2530 |
|
2022
Q2 | – | Sell |
-23,400
| Closed | -$270K | – | 2494 |
|
2022
Q1 | $270K | Buy |
23,400
+19,800
| +550% | +$228K | ﹤0.01% | 1264 |
|
2021
Q4 | $27K | Buy |
3,600
+3,050
| +555% | +$22.9K | ﹤0.01% | 1870 |
|
2021
Q3 | $7 | Hold |
550
| – | – | ﹤0.01% | 2242 |
|
2021
Q2 | $11 | Hold |
550
| – | – | ﹤0.01% | 2216 |
|
2021
Q1 | $12 | Hold |
550
| – | – | ﹤0.01% | 2190 |
|
2020
Q4 | $16K | Sell |
550
-1,350
| -71% | -$39.3K | ﹤0.01% | 2155 |
|
2020
Q3 | $41K | Buy |
+1,900
| New | +$41K | ﹤0.01% | 1876 |
|